Health Desk: 21 March 2018: In a major step forward in the development of a once-daily 'male pill', researchers have found an experimental oral contraceptive to be safe in men with hormone responses consistent with effective contraception.
The findings presented at the Endocrine Society's annual meeting in Chicago showed that the new pill -- called dimethandrolone undecanoate, or DMAU -- appears to be safe when used daily for a month.
Like the pill for women, DMAU combines activity of an androgen (male hormone) like testosterone, and a progestin, and is taken once a day, said the study's senior investigator, Stephanie Page, Professor of Medicine at the University of Washington in Seattle.
"Many men say they would prefer a daily pill as a reversible contraceptive, rather than long-acting injections or topical gels, which are also in development," Page pointed out.
However, DMAU contains undecanoate, a long-chain fatty acid, which Page said slows this clearance.